These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28842309)

  • 21. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications.
    Jansook P; Ogawa N; Loftsson T
    Int J Pharm; 2018 Jan; 535(1-2):272-284. PubMed ID: 29138045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
    Jablan J; Szalontai G; Jug M
    J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclodextrins in topical drug formulations: theory and practice.
    Loftsson T; Masson M
    Int J Pharm; 2001 Aug; 225(1-2):15-30. PubMed ID: 11489551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclodextrin solubilization of ETH-615, a zwitterionic drug.
    Loftsson T; Petersen DS
    Drug Dev Ind Pharm; 1998 Apr; 24(4):365-70. PubMed ID: 9876597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-assembled γ-cyclodextrin as nanocarriers for enhanced ocular drug bioavailability.
    Jansook P; Loftsson T
    Int J Pharm; 2022 Apr; 618():121654. PubMed ID: 35278603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
    Kopecký F; Kopecká B
    Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure.
    Vinarov Z; Katev V; Radeva D; Tcholakova S; Denkov ND
    Drug Dev Ind Pharm; 2018 Apr; 44(4):677-686. PubMed ID: 29164955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclodextrins and Drug Membrane Permeation: Thermodynamic Considerations.
    Sripetch S; Prajapati M; Loftsson T
    J Pharm Sci; 2022 Sep; 111(9):2571-2580. PubMed ID: 35487262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: a review.
    Mura P
    J Pharm Biomed Anal; 2014 Dec; 101():238-50. PubMed ID: 24680374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis.
    Semalty A
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1255-72. PubMed ID: 24909802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-association and cyclodextrin solubilization of drugs.
    Loftsson T; Magnúsdóttir A; Másson M; Sigurjónsdóttir JF
    J Pharm Sci; 2002 Nov; 91(11):2307-16. PubMed ID: 12379916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD.
    Granero G; de Bertorello MM; Longhi M
    Boll Chim Farm; 2002; 141(1):63-6. PubMed ID: 12064060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
    Faucci MT; Mura P
    Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers.
    Loftsson T
    Pharmazie; 1998 Nov; 53(11):733-40. PubMed ID: 9853355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-Cyclodextrin-dextran polymers for the solubilization of poorly soluble drugs.
    di Cagno M; Terndrup Nielsen T; Lambertsen Larsen K; Kuntsche J; Bauer-Brandl A
    Int J Pharm; 2014 Jul; 468(1-2):258-63. PubMed ID: 24746415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
    Muankaew C; Loftsson T
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study on solubilization of poorly soluble drugs by cyclodextrins and micelles: complexation and binding characteristics of sulfamethoxazole and trimethoprim.
    Göktürk S; Çalışkan E; Talman RY; Var U
    ScientificWorldJournal; 2012; 2012():718791. PubMed ID: 22649316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.